(EMAILWIRE.COM, May 01, 2012 ) New York, NY -- Monday proved to be a ho-hum day for the broad markets, with not much excitements as the major markers trading slightly in the red for the duration of trading. There were, however, some stocks on the move making noise while a few nice volume plays were worth noting because, as they say, many times volume precedes price...
Premier Alliance Group (PIMO) was a stock to watch last week as trading volume started to pick up, and that volume boost carried into the new trading week, too, as PIMO shares traded on well more than triple the daily average to open the new trading week. As previously discussed, Premier has been growing its customer base over the past few years and increasing its revenues and earnings, as well, all while completing some key acquisitions and mergers that have thrust the company into the heart of one of the most rapidly growing sectors - energy efficiency and devising methods and programs to maximize that efficiency.
The momentum of Amazon's (AMZN) huge price and volume moves of late last week carried into the new trading week, too, albeit on a more modest scale. Impressive first quarter earnings numbers propelled AMZN shares fifteen percent higher on Friday - a move that was supported by nearly four times the daily trading volume - and that encouraging mood led to a two percent spike on Monday on above-average volume.
This will still be a story to watch, however, with Microsoft (MSFT) making a savvy move into Amazon's comfort zone by teaming up with Barnes & Noble (BKS) to boost the Nook business.
On the note of volume, the Microsoft news sparked volume of roughly twenty times what the Barnes & Noble stock usually sees. That huge boost supported a BKS move of over fifty percent for the day.
Although losing much of their early gains for the day by the closing bell on Monday, shares of Synergy Pharmaceuticals (SGYP) traded on increased volume for the duration of the trading session. The early price boost also put SGYP on the stock watch list for the day, but it's the volume boost that may be more intriguing, given the momentum built during last week's trading.
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
The goal of VFC's Stock House is to bring new ideas, companies and discussions to investors and readers. With respect to the increased amount of time necessary to maintain quality, VFC's Stock House is at times compensated from third parties to research and cover certain companies that fit the profile of what interests the readers of VFC's Stock House. While taking compensation poses as an inherent perception of bias in coverage, the ultimate goal is to bring ideas and information to the eyes of readers, who can then decide what is and what is not relevant.